IRIS

LUDOVISI, MANUELA

LUDOVISI, MANUELA  

Dipartimento di Medicina clinica, sanità pubblica, scienze della vita e dell'ambiente  

Mostra records
Risultati 1 - 20 di 42 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications 1-gen-2003 Ferrandina, Gabriella; Pierelli, Luca; Perillo, Alessandro; Rutella, Sergio; Ludovisi, Manuela; Leone, Giuseppe; Mancuso, Salvatore; Scambia, Giovanni
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer 1-gen-2003 D'Agostino, G.; Ferrandina, G.; Ludovisi, M.; Testa, A.; Lorusso, D.; Gbaguidi, N.; Breda, E.; Mancuso, S.; Scambia, G.
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients 1-gen-2003 Lorusso, D.; Ferrandina, G.; Greggi, S.; Gadducci, A.; Pignata, S.; Tateo, S.; Biamonte, R.; Manzione, L.; Di Vagno, G.; Ferrau, F.; Scambia, G.; Garganese, G.; Legge, F.; Ludovisi, M.; Fanucchi, A.; Cosio, S.; Tambaro, R.; Iaffaioli, R. V.; Pascale, F. G.; Germano, D.; Lapresa, M.
Sonographic features of decidualized ovarian endometriosis suspicious for malignancy 1-gen-2004 Fruscella, E.; Testa, A. C.; Ferrandina, G.; Manfredi, R.; Zannoni, G. F.; Ludovisi, M.; Malaggese, M.; Scambia, G.
Frozen section examination of pelvic lymph nodes in endometrial and cervical cancer: Accuracy in patients submitted to neoadjuvant treatments 1-gen-2004 Fanfani, F.; Ludovisi, M.; Zannoni, G. F.; Distefano, M.; Fagotti, A.; Ceccaroni, M.; Mancuso, S.; Scambia, G.
The role of sonographic examination in the follow-up of gynecological neoplasms 1-gen-2005 Testa, A. C.; Fruscella, E.; Ludovisi, M.; De Vincenzo, R.; Malaggese, M.; Corrado, G.; Basso, D.; Scambia, G.; Ferrandina, G.
Ultrasound features of different histopathological subtypes of borderline ovarian tumors 1-gen-2005 Fruscella, E.; Testa, A. C.; Ferrandina, G.; De Smet, F.; Van Holsbeke, C.; Scambias, G.; Zannonii, G. F.; Ludovisi, M.; Achten, R.; Amant, F.; Vergote, I.; Timmerman, D.
Does quantitative analysis of three-dimensional power Doppler angiography have a role in the diagnosis of malignant pelvic solid tumors? A preliminary study 1-gen-2005 Testa, A. C.; Ajossa, S.; Ferrandina, G.; Fruscella, E.; Ludovisi, M.; Malaggese, M.; Scambia, G.; Melis, G. B.; Guerriero, S.
Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma [1] 1-gen-2005 Ferrandina, G.; Distefano, M.; Ludovisi, M.; Fagotti, A.; Fanfani, F.; Scambia, G.
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: Updated results and long-term survival 1-gen-2005 Ferrandina, G.; Paris, I.; Ludovisi, M.; D'Agostino, G.; Testa, A.; Lorusso, D.; Zanghi, M.; Pisconti, S.; Pezzella, G.; Adamo, V.; Breda, E.; Scambia, G.
Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: A pilot study 1-gen-2005 Fagotti, A.; Fanfani, F.; Ludovisi, M.; Voi, R. L.; Bifulco, G.; Testa, A. C.; Scambia, G.
Ultrasound and color power Doppler in the detection of metastatic omentum: A prospective study 1-gen-2006 Testa, A. C.; Ludovisi, M.; Savelli, L.; Fruscella, E.; Ghi, T.; Fagotti, A.; Scambia, G.; Ferrandina, G.
Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy 1-gen-2007 Ferrandina, G.; Distefano, M.; Ludovisi, M.; Morganti, A.; Smaniotto, D.; D'Agostino, G.; Fanfani, F.; Scambia, G.
Imaging in gynecological disease (1): Ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor 1-gen-2007 Testa, A. C.; Ferrandina, G.; Timmerman, D.; Savelli, L.; Ludovisi, M.; Van Holsbeke, C.; Malaggese, M.; Scambia, G.; Valentin, L.
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: A phase II study 1-gen-2007 Ferrandina, G.; Ludovisi, M.; De Vincenzo, R.; Salutari, V.; Lorusso, D.; Colangelo, M.; Prantera, T.; Valerio, M. R.; Scambia, G.
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer 1-gen-2008 Ferrandina, G.; Ludovisi, M.; Lorusso, D.; Pignata, S.; Breda, E.; Savarese, A.; Del Medico, P.; Scaltriti, L.; Katsaros, D.; Priolo, D.; Scambia, G.
In reply 1-gen-2008 Ferrandina, G.; Ludovisi, M.; Scambia, G.; Pignata, S.
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 1-gen-2008 Ferrandina, G.; Fanfani, F.; Ludovisi, M.; Fagotti, A.; Carbone, A.; Zannoni, G.; Guerriero, M.; Petrillo, M.; Scambia, G.
Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer 1-gen-2008 Ferrandina, G.; Ludovisi, M.; Corrado, G.; Carone, V.; Petrillo, M.; Scambia, G.
Preoperative local staging of endometrial cancer: Transvaginal sonography vs. magnetic resonance imaging 1-gen-2008 Savelli, L.; Ceccarini, M.; Ludovisi, M.; Fruscella, E.; DE Iaco, P. A.; Salizzoni, E.; Mabrouk, M.; Manfredi, R.; Testa, A. C.; Ferrandina, G.